Using irAOP for non-clinical safety evaluation of biotechnology-derived pharmaceuticals and ATMPs: a paradigm shift into a systematic and holistic framework
The chances and opportunities in modern biology inspired devising new therapeutics are mind blowing. The promises reach from successfully treating so-far incurable diseases like cancer and certain infections, to modulating and fine tuning the immune response to prolong the lifespan by inhibiting agi...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2024-12-01
|
| Serija: | Journal of Immunotoxicology |
| Teme: | |
| Online dostop: | https://www.tandfonline.com/doi/10.1080/1547691X.2024.2390920 |
| Oznake: |
Brez oznak, prvi označite!
|
